Middle East & Africa Bioequivalence Studies Market Size & Outlook
Related Markets
MEA bioequivalence studies market highlights
- The MEA bioequivalence studies market generated a revenue of USD 20.7 million in 2023.
- The market is expected to grow at a CAGR of 5.7% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating molecule type in 2023.
- Large Molecule is the most lucrative molecule type segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 20.7 million |
| Market revenue in 2030 | USD 30.5 million |
| Growth rate | 5.7% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | IQVIA Holdings Inc, Icon PLC, Charles River Laboratories International Inc, Labcorp Drug Development, Kymos Pharma Services, Spectris PLC |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.8% of the global bioequivalence studies market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 279.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bioequivalence Studies Market Scope
Bioequivalence Studies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Spectris PLC | View profile | 6979 | 44-46 Aldwych, Melbourne House, 5th Floor, London, United Kingdom, WC2B 4LL | https://www.spectris.com |
| Kymos Pharma Services | View profile | 101-250 | Barcelona, Catalonia, Spain, Europe | http://www.kymos.com/ |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
Middle East & Africa bioequivalence studies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioequivalence studies market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 60.39% in 2023. Horizon Databook has segmented the Middle East & Africa bioequivalence studies market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
- Middle East & Africa Bioequivalence Studies Molecule Type Outlook (Revenue, USD Million, 2018-2030)
- Small Molecule
- Large Molecule
- Middle East & Africa Bioequivalence Studies Dosage Form Outlook (Revenue, USD Million, 2018-2030)
- Solid Oral Dosage
- Parenteral Formulations
- Topical Products
- Others
- Middle East & Africa Bioequivalence Studies Therapeutic Area Outlook (Revenue, USD Million, 2018-2030)
- Hematology
- Immunology
- Neurology
- Metabolic Disorders
- Others
- Oncology
Reasons to subscribe to Middle East & Africa bioequivalence studies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa bioequivalence studies market databook
-
Our clientele includes a mix of bioequivalence studies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa bioequivalence studies market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa bioequivalence studies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA bioequivalence studies market report size, by country, 2018-2030 (US$M)
Middle East & Africa Bioequivalence Studies Market Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
